9%
,MULTIPLE CHOICE 9%
1. Knowledge of pharmacology aids the dental professional in 9% 9% 9% 9% 9% 9% 9%
a. obtaining a patient’s health history. 9% 9% 9% 9%
b. administering drugs in the office. 9% 9% 9% 9%
c. handling emergency situations. 9% 9%
d. selection of a nonprescription medication. 9% 9% 9% 9%
e. All of the above. 9% 9% 9%
ANS: 9 % E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
of pharmacology helps in understanding and interpreting patients’ responses to health history questi
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ons. Knowledge of the therapeutic and adverse effects of medications obviously helps in their prop
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
er administration in the office. Emergency situations may be caused by drugs or treated by drugs; t
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
hus, knowledge of pharmacology is of great help, especially because a rapid response is sometimes
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
required. A clear understanding of the concepts of drug action, drug handling by the body, and dr
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ug interactions will allow the dental practitioner to make proper judgments and grasp the concepts
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
relevant to new drug therapies on the market.
9% 9% 9% 9% 9% 9% 9%
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medica
9 % 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
tion Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienis
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
t (Nonprescription Medication) | pp. 2-3
9% OBJ: 1 9% 9% 9% 9%
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
2. Which of the following statements is true regarding planning appointments?
9% 9% 9% 9% 9% 9% 9% 9% 9%
a. Whether or not patients are taking medication for systemic diseases is of litt
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
le
consequence in the dental office. 9% 9% 9% 9%
b. Asthmatic patients should have dental appointments in the morning. 9% 9% 9% 9% 9% 9% 9% 9%
c. Diabetic patients usually have fewer problems with a morning appointment
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
compared with afternoon appointments. 9% 9% 9%
d. Both B and C are true. 9% 9% 9% 9% 9%
ANS: 9 % D
Asthmatic patients who experience dental anxiety should schedule their appointments when they ar
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
problems with a morning appointment. Patients taking medication for systemic diseases may requir
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e special handling in the dental office.
9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |
9 % 9% 9% 9% 9% 9% 9% 9% 9%
p. 3 OBJ: 1
9% 9%TOP: NBDHE, 6.0. Pharmacology
9 % 9 % 9% 9%
,3. Nutritional or herbal supplements 9% 9% 9%
a. carry the U.S. Food and Drug Administration (FDA) approval for disease state
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
s.
b. are not drugs. 9% 9%
c. can cause adverse effects. 9% 9% 9%
d. will not interact with other drugs the patient may be taking.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ANS: 9 % C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutriti
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
onal or herbal supplements do not carry FDA approval for treating disease states. These supplements
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
are drugs and can cause adverse effects and interact with different drugs.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
9 % 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
p. 3 OBJ: 1
9% 9% TOP: NBDHE, 6.0. Pharmacology
9 % 9 % 9% 9%
4. Which type of drug name usually begins with a lowercase letter?
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
a. Brand name 9%
b. Code name 9%
c. Generic name 9%
d. Trade name 9%
ANS: 9 % C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the dr
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ug. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
the name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Alt
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
hough the brand name is technically the name of the company marketing the product, this term is o
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ften used interchangeably with the trade name. The code name is the initial term used within a pha
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
rmaceutical company to refer to a drug while it is undergoing investigation and is often a combinat
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ion of capital letters and numbers, the letters representing an abbreviation of the company name.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3
9 % 9% 9% 9% 9% 9% 9 %
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
5. A 9% drug’s generic name is selected by the
9% 9% 9% 9% 9% 9%
a. pharmaceutical company manufacturing it. 9% 9% 9%
b. Food and Drug Administration (FDA).
9% 9% 9% 9%
c. U.S. Adopted Name Council.
9% 9% 9%
d. Federal Patent Office. 9% 9%
ANS: 9 % C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The pha
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
rmaceutical company manufacturing the drug clearly has an influence on the generic name given its
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
drug, but the final decision is not the company’s.
9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Recall REF: Drug Names | p. 4 9 % 9% 9% 9% 9%
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9 % 9% 9%
6. Which of the following is true concerning generic and trade names of drugs?
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
a. A drug may only have one generic name and one trade nam
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e.
, b. A drug may only have one generic name, but it may have several trade nam
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
es.
c. A drug may have several generic names, but it may only have one trade na
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
me.
d. A drug may have several generic names and several trade names.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ANS: 9 % B
Each drug has only one generic name but may have several trade names. For each drug, there is on
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ly one generic name. It is not capitalized, and it becomes the “official” name of the drug. The phar
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
maceutical company discovering the drug gives the drug a trade name. The trade name is protected
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term exten
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
sions. Although the brand name is technically the name of the company marketing the product, it is
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%often used interchangeably with the trade name.
9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3
9 % 9% 9% 9% 9% 9% 9 %
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
or therapeutically equivalent are said to differ in
9% 9% 9% 9% 9% 9% 9%
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. 9%
ANS: 9 % C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. Thes
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e products are said to differ in their bioavailability. The potency of a drug is a function of the amou
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
nt of drug required to produce an effect. The efficacy is the maximum intensity of effect or respon
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
se that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
the experimental animals divided by the effective dose for 50% of the experimental animals. If the
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%value of the therapeutic index is small, toxicity is more likely.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ:
9 % 9% 9% 9% 9% 9% 9% 9% 9 % 4
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
8. How many years must pass after a drug patent expires before other drug companies can market t
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
he same compound as a generic drug?
9% 9% 9% 9% 9% 9%
a. 20 years 9%
b. 17 years 9%
c. 7 years 9%
d. 0 years 9%
ANS: 9 % D
Once a drug patent expires, competing companies may immediately market the same compound in
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
, plus the patent term extensions.
9% 9% 9% 9% 9%
DIF: Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ:
9 % 9% 9% 9% 9% 9% 9% 9% 9 % 4
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
,MULTIPLE CHOICE 9%
1. Knowledge of pharmacology aids the dental professional in 9% 9% 9% 9% 9% 9% 9%
a. obtaining a patient’s health history. 9% 9% 9% 9%
b. administering drugs in the office. 9% 9% 9% 9%
c. handling emergency situations. 9% 9%
d. selection of a nonprescription medication. 9% 9% 9% 9%
e. All of the above. 9% 9% 9%
ANS: 9 % E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
of pharmacology helps in understanding and interpreting patients’ responses to health history questi
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ons. Knowledge of the therapeutic and adverse effects of medications obviously helps in their prop
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
er administration in the office. Emergency situations may be caused by drugs or treated by drugs; t
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
hus, knowledge of pharmacology is of great help, especially because a rapid response is sometimes
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
required. A clear understanding of the concepts of drug action, drug handling by the body, and dr
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ug interactions will allow the dental practitioner to make proper judgments and grasp the concepts
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
relevant to new drug therapies on the market.
9% 9% 9% 9% 9% 9% 9%
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medica
9 % 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
tion Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienis
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
t (Nonprescription Medication) | pp. 2-3
9% OBJ: 1 9% 9% 9% 9%
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
2. Which of the following statements is true regarding planning appointments?
9% 9% 9% 9% 9% 9% 9% 9% 9%
a. Whether or not patients are taking medication for systemic diseases is of litt
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
le
consequence in the dental office. 9% 9% 9% 9%
b. Asthmatic patients should have dental appointments in the morning. 9% 9% 9% 9% 9% 9% 9% 9%
c. Diabetic patients usually have fewer problems with a morning appointment
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
compared with afternoon appointments. 9% 9% 9%
d. Both B and C are true. 9% 9% 9% 9% 9%
ANS: 9 % D
Asthmatic patients who experience dental anxiety should schedule their appointments when they ar
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
problems with a morning appointment. Patients taking medication for systemic diseases may requir
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e special handling in the dental office.
9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |
9 % 9% 9% 9% 9% 9% 9% 9% 9%
p. 3 OBJ: 1
9% 9%TOP: NBDHE, 6.0. Pharmacology
9 % 9 % 9% 9%
,3. Nutritional or herbal supplements 9% 9% 9%
a. carry the U.S. Food and Drug Administration (FDA) approval for disease state
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
s.
b. are not drugs. 9% 9%
c. can cause adverse effects. 9% 9% 9%
d. will not interact with other drugs the patient may be taking.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ANS: 9 % C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutriti
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
onal or herbal supplements do not carry FDA approval for treating disease states. These supplements
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
are drugs and can cause adverse effects and interact with different drugs.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
9 % 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
p. 3 OBJ: 1
9% 9% TOP: NBDHE, 6.0. Pharmacology
9 % 9 % 9% 9%
4. Which type of drug name usually begins with a lowercase letter?
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
a. Brand name 9%
b. Code name 9%
c. Generic name 9%
d. Trade name 9%
ANS: 9 % C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the dr
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ug. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
the name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Alt
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
hough the brand name is technically the name of the company marketing the product, this term is o
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ften used interchangeably with the trade name. The code name is the initial term used within a pha
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
rmaceutical company to refer to a drug while it is undergoing investigation and is often a combinat
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ion of capital letters and numbers, the letters representing an abbreviation of the company name.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3
9 % 9% 9% 9% 9% 9% 9 %
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
5. A 9% drug’s generic name is selected by the
9% 9% 9% 9% 9% 9%
a. pharmaceutical company manufacturing it. 9% 9% 9%
b. Food and Drug Administration (FDA).
9% 9% 9% 9%
c. U.S. Adopted Name Council.
9% 9% 9%
d. Federal Patent Office. 9% 9%
ANS: 9 % C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The pha
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
rmaceutical company manufacturing the drug clearly has an influence on the generic name given its
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
drug, but the final decision is not the company’s.
9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Recall REF: Drug Names | p. 4 9 % 9% 9% 9% 9%
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9 % 9% 9%
6. Which of the following is true concerning generic and trade names of drugs?
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
a. A drug may only have one generic name and one trade nam
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e.
, b. A drug may only have one generic name, but it may have several trade nam
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
es.
c. A drug may have several generic names, but it may only have one trade na
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
me.
d. A drug may have several generic names and several trade names.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ANS: 9 % B
Each drug has only one generic name but may have several trade names. For each drug, there is on
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
ly one generic name. It is not capitalized, and it becomes the “official” name of the drug. The phar
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
maceutical company discovering the drug gives the drug a trade name. The trade name is protected
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term exten
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
sions. Although the brand name is technically the name of the company marketing the product, it is
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%often used interchangeably with the trade name.
9% 9% 9% 9% 9% 9%
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3
9 % 9% 9% 9% 9% 9% 9 %
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
or therapeutically equivalent are said to differ in
9% 9% 9% 9% 9% 9% 9%
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. 9%
ANS: 9 % C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. Thes
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
e products are said to differ in their bioavailability. The potency of a drug is a function of the amou
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
nt of drug required to produce an effect. The efficacy is the maximum intensity of effect or respon
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
se that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
the experimental animals divided by the effective dose for 50% of the experimental animals. If the
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%value of the therapeutic index is small, toxicity is more likely.
9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ:
9 % 9% 9% 9% 9% 9% 9% 9% 9 % 4
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
8. How many years must pass after a drug patent expires before other drug companies can market t
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
he same compound as a generic drug?
9% 9% 9% 9% 9% 9%
a. 20 years 9%
b. 17 years 9%
c. 7 years 9%
d. 0 years 9%
ANS: 9 % D
Once a drug patent expires, competing companies may immediately market the same compound in
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9
%trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date
9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9% 9%
, plus the patent term extensions.
9% 9% 9% 9% 9%
DIF: Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ:
9 % 9% 9% 9% 9% 9% 9% 9% 9 % 4
TOP: NBDHE, 6.0. Pharmacology
9 % 9% 9%
